World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT01329523
Date of registration: 10/01/2011
Primary sponsor: Avera McKennan Hospital & University Health Center
Public title: A Study to Compare Genetic Variations of IGF-I and IGF-II
Scientific title: A Non-Randomized Controlled Cross-Sectional Study to Compare Genetic Variations of IGF-I and IGF-II in Patients With Moderate to Severe Dementia and Younger Family Members, in Relation to Age-Matched Unaffected Controls
Date of first enrolment: November 2010
Target sample size: 50
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT01329523
Study type:  Observational
Study design:  Observational Model: Cohort, Time Perspective: Prospective  
Countries of recruitment
United States
Contacts
Name:   Umesh Chakunta, MD
Address: 
Telephone:
Email:
Affiliation:  Avera McKennan Hospital & University Health Center
Key inclusion & exclusion criteria

Inclusion Criteria:

- Men and women between the ages of 50 and 81 years old who have a diagnosis of
dementia

- Men and women who are at least 18 years old and are biologically related to the study
subject with dementia

- Control subjects must not have a diagnosis of dementia and must be matched in age to
the study subjects with dementia

Exclusion Criteria:

- Biological family members of the dementia patient who are either younger than 17
years of age or older than the patient with dementia

- Biological family members with a diagnosis of dementia

- Age-matched control subjects with a diagnosis of dementia



Age minimum: 50 Years
Age maximum: 81 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Dementia
Intervention(s)
Primary Outcome(s)
Genetic polymorphisms of insulin-like growth factors [Time Frame: Single clinic visit (day 1)]
Secondary Outcome(s)
Genetic testing of Apolipoprotein (APO) E4 [Time Frame: Single clinic visit (day 1)]
Secondary ID(s)
AIHBG-1370-IGF
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history